AGL in three months: buy, wait or sell?
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
- Buy / Wait / Sell rating
- 3-month target price
- Bear · Base · Bull
- vs. the market
What happened with AGL today?
No read yet
Uses news and trading volume to explain the day’s move and how it relates to the market.
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
agilon health, inc. partners with existing community-based primary care groups through its Total Care Model. It supplies technology, staff, processes and capital to help practices identify gaps in care and manage patients’ overall healthcare needs. The physicians remain independent; agilon does not employ them or control their clinical decisions.
Nearly all revenue comes from Medicare Advantage insurers. Through local entities that bear financial risk, agilon contracts for a monthly payment for each patient assigned to its physician partners and accepts responsibility for a broad range of medical costs, including hospital and specialist care. Insurers generally pay the medical claims from contract funding and distribute the remaining surplus to agilon. Physician groups share in savings through incentive payments. If medical costs exceed the contracted revenue, agilon bears the shortfall, which is typically uncapped.
The business depends on retaining physician partners and a small group of insurers that supply a significant share of revenue. Humana, Aetna and UnitedHealthcare account for substantial membership in certain markets. Payments also depend on Medicare reimbursement rules and patients’ documented health conditions, not just enrollment. agilon is not licensed to practice medicine, and its physician incentives must not reward reducing or limiting medically necessary care.
The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.
Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.
Watch Aetna and UnitedHealthcare, important payors absent from this list: agilon’s results also depend on keeping favorable Medicare Advantage contracts with them and holding medical costs within those payments.
Astrana Health Inc. and agilon face the same squeeze when medical costs rise against fixed monthly payments from insurers; both partner with independent physicians to manage insured patients’ care. Watch the medical-cost risk in Astrana’s Care Partners business, which organizes physician networks across Medicare, Medicaid and commercial insurance.
Humana pays agilon to manage its Medicare Advantage members’ care, but its CenterWell senior primary-care business also competes with agilon’s physician partnerships. Watch Humana’s contract renewals and renegotiations: less favorable terms or termination can reduce agilon’s revenue or patient base.
Privia Health Group, Inc. competes with agilon for independent physician groups, helping them negotiate insurer payments and join care arrangements that tie payment to quality and cost. Watch physician groups joining Privia’s regional Medical Groups: these are the relationships agilon also seeks for its Medicare-focused care model.
Evolent Health, Inc and agilon both depend on health-plan payments covering treatment costs: Evolent takes responsibility for specialty-care claims, while agilon covers a broader range of patient care. Watch Evolent’s Performance Suite, where it generally receives fixed monthly payments per member and bears the medical claims within its contracted scope.
agilon health, inc. earningsThis company
agilon health receives monthly payments from health plans and bears defined medical costs, so this report will show whether claims are still outrunning the revenue tied to members.
Compare medical services revenue with medical services expense, and check the expense as a share of total revenue. If expense falls below the related revenue and its share declines, member premiums are covering care more adequately and the risk business is recovering margin. If expense still exceeds total revenue, agilon is spending more on care than it takes in overall, so medical costs continue to squeeze the business.
Astrana Health Inc. earningsASTH
Astrana Health’s Care Partners organizes physician networks to manage patient care; its medical costs against fixed monthly payments show whether the squeeze on agilon health’s risk-bearing model is also affecting another physician-partner business.
Read Care Partners’ medical costs against its fixed monthly payments. Costs contained within those payments would suggest physician networks can manage care without the squeeze overwhelming the model, a constructive signal for agilon health’s risk business. Costs running ahead of payments would show that a similar model is under pressure too, leaving agilon’s medical-cost risk salient.
Privia Health Group, Inc. earningsPRVA
Privia Health’s regional medical groups bring independent physicians onto its platform; its report shows whether doctors are still joining, a direct read on competition for the physician partners agilon health needs.
Look for additions to Privia’s regional medical groups and whether that network is expanding. More additions suggest physicians still want a platform that negotiates insurer payments and ties care to quality and cost, sharpening competition for agilon’s partners. Slower additions would soften that competitive signal, but would not prove agilon is recruiting successfully.
Humana Inc. earningsHUM
Humana pays agilon health to manage care for Medicare Advantage members; Humana’s report on contract renewals and renegotiations can signal risks to agilon’s payments and patient base.
Watch Humana’s renewals and renegotiations with care providers, including changes to terms or scope. Workable renewals would support the payments and patient base tied to agilon’s relationship; worse terms or termination could reduce both. Humana also runs a senior primary-care business that competes for physician relationships, but contract disclosures concern the payer relationship and do not prove agilon’s own contract has changed.